Boehringer Ingelheim has obtained marketing approval for Striverdi Respimat (olodaterol), a long-lasting bronchodilator indicated for chronic obstructive pulmonary disease (COPD), in the UK, Denmark and Iceland. This approval is based ...
Santen Pharmaceutical, a manufacturer of ophthalmic and anti-rheumatic pharmaceuticals, has introduced TAPROS MINI ophthalmic solution 0.0015%, indicated for glaucoma and ocular hypertension. TAPROS MINI ophthalmic solution contains ...
US-based Dynex Technologies has obtained a four year marketing approval from the State Food and Drug Administration of China for its DSX automated enzyme-linked immunosorbent assay (ELISA) processing system in China. The DSX ELISA ...
Tags: Dynex, Elisa Processing System
Danish pharmaceutical company H. Lundbeck and Japanese drugmaker Otsuka Pharmaceutical have announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for ...
Danish pharmaceutical company Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the marketing approval for its NovoEight (turoctocog alfa), ...
Tags: Novo Nordisk, Novoeight
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
GlaxoSmithKline and biopharmaceutical company Theravance have announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing approval for fluticasone furoate/vilanterol ...
Biopharmaceutical contract manufacturer Sigma-Tau PharmaSource has entered into a manufacturing services agreement with Aradigm, a specialty pharmaceutical firm focused on the development and commercialization of drugs delivered by ...
The Israeli Ministry of Health has granted an approval to Medigus for registering its SRS system, which is designed to treat gastroesophageal reflux disease, in the Israeli Register of Medical Equipment and Accessories (MEA). The SRS ...
Tags: SRS system, Medicine
Ceptaris Therapeutics has obtained FDA marketing approval for Valchlor (mechlorethamine) gel to topically treat stage IA and IB mycosis fungoides-type cutaneous T-Cell lymphoma (CTCL) patients who were exposed to skin-directed therapy ...
Tags: Valchlor Gel, Ceptaris
The Irish Medicines Board and the Netherlands' Medicines Evaluations Board have granted national phase approvals to Apricus Biosciences' Vitaros, indicated to treat patients with erectile dysfunction (ED). Vitaros now has four national ...
Tags: Apricus Bio, Medicine
Biogen has announced acceptance of marketing applications of Plegridy(peginterferon beta-1a) for review by the US and EU regulatory authorities. Plegridy, a member of the interferon class of treatments, is a pegylated subcutaneous ...
Tags: Biogen, Marketing Applications
Daiichi Sankyo Company has launched Pralia subcutaneous injection 60mg syringe (generic name denosumab) for the treatment of osteoporosis, following its manufacturing and marketing approval in Japan. Designed to specifically inhibit an ...
Tags: Daiichi Sankyo, Syringe
Japan-based Dainippon Sumitomo Pharma (DSP) has completed the construction of its new Chemistry Research Building, located at the Osaka Research Center, with a total floor area of 16,322m2. Started in January 2012, construction cost of ...
Astellas Pharma and Medivation have announced the Health Canada approval of Xtandi (enzalutamide) capsules to treat metastatic castration-resistant prostate cancer. The oral, once-daily androgen receptor inhibitor is indicated for ...
Tags: Astellas Pharma, Medicine